nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Tocilizumab

Decreased level of haptoglobin: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Hermans MAW, et al. A puzzling haptoglobin level in a patient who is treated with tocilizumab. Netherlands Journal of Medicine 77: 128, No. 3, Apr 2019 - Netherlands

Titel: Tocilizumab
Decreased level of haptoglobin: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63878-x

Ciclosporin/mycophenolate mofetil

Case report

Nivolumab

Case report

Methylprednisolone

Case report

Norepinephrine

Case report

Cefuroxime/ibuprofen

Case report

Iguratimod/warfarin

Case report

Springer Medizin

Tocilizumab

Decreased level of haptoglobin: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Ciclosporin/mycophenolate mofetil

Nivolumab

Methylprednisolone

Norepinephrine

Cefuroxime/ibuprofen

Iguratimod/warfarin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Ciclosporin/mycophenolate mofetil

Nivolumab

Methylprednisolone

Norepinephrine

Cefuroxime/ibuprofen

Iguratimod/warfarin